Total medical devices industry M&A deals worth $4.6bn were announced in North America in July 2022, led by Amazon.com’s $3.9bn acquisition of 1Life Healthcare, according to GlobalData’s deals database.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
- Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
The value marked an increase of 529.9% over the previous month of $735.1m and a drop of 26.5% when compared with the last 12-month average of $6.3bn.
North America held a 99.78% share of the global medical devices industry M&A deal value that totalled $4.64bn in July 2022. With a 99.78% share and deals worth $4.63bn, the US was the top country in North America’s M&A deal value across medical devices industry.
In terms of M&A deal activity, North America recorded 24 deals during July 2022, marking an increase of 20.00% over the previous month and a flat growth over the 12-month average. The US recorded 21 deals during the month.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataNorth America medical devices industry M&A deals in July 2022: Top deals
The top five medical devices industry M&A deals accounted for 99.8% of the overall value during July 2022.
The combined value of the top five medical devices deals stood at $4.62bn, against the overall value of $4.6bn recorded for the month.
The top five medical devices industry M&A deals of July 2022 tracked by GlobalData were:
1) Amazon.com $3.9bn acquisition deal with 1Life Healthcare
2) The $500m acquisition of OpenEye Scientific Software by Cadence Design Systems
3) Health Sciences Acquisitions2 $158m acquisition deal with Orchestra BioMed
4) The $52.5m acquisition of Palamedrix by SomaLogic
5) Inotiv $11m acquisition deal with Protypia
